The WACC of Erytech Pharma SA (ERYP.PA) is 6.3%.
| Range | Selected | |
| Cost of equity | 6.50% - 10.10% | 8.30% |
| Tax rate | -% - 35.60% | 17.80% |
| Cost of debt | 4.00% - 7.00% | 5.50% |
| WACC | 5.2% - 7.3% | 6.3% |
| Category | Low | High |
| Long-term bond rate | 3.1% | 3.6% |
| Equity market risk premium | 6.2% | 7.2% |
| Adjusted beta | 0.55 | 0.83 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 6.50% | 10.10% |
| Tax rate | -% | 35.60% |
| Debt/Equity ratio | 1.01 | 1.01 |
| Cost of debt | 4.00% | 7.00% |
| After-tax WACC | 5.2% | 7.3% |
| Selected WACC | 6.3% | |